Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19.

Herman, Anne;Matthews, Marine;Mairlot, Margaux;Nobile, Laura;Baeck, Marie;et.al.
(2020) Journal of the European Academy of Dermatology and Venereology — Vol. 34, n° 12, p. e768-e700 (2020)

Files

2020_Herman_J_Eur_Acad_Dermatol_Venereol.pdf
  • Open Access
  • Adobe PDF
  • 335.01 KB

Details

Authors
  • Herman, Anneorcid-logoUCLouvain
    Author
  • Matthews, MarineUCLouvain
    Author
  • Mairlot, MargauxUCLouvain
    Author
  • Nobile, LauraUCLouvain
    Author
  • Famerée, LaetitiaUCLouvain
    Author
  • Jacquet, Luc-MarieUCLouvain
    Author
  • Baeck, Marieorcid-logoUCLouvain
    Author
Show more
Abstract
Dear Editor, Skin rashes associated with COVID‐19 include eruptions induced by drugs prescribed for management of this infection. We report a case of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a patient with COVID‐19. [...]
Affiliations

Citations

Herman, A., Matthews, M., Mairlot, M., Nobile, L., Famerée, L., Jacquet, L.-M., & Baeck, M. (2020). Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19. Journal of the European Academy of Dermatology and Venereology, 34(12), e768-e700. https://doi.org/10.1111/jdv.16838 (Original work published 2020)